Prof. Feng Liu 刘锋
Chief Physician, Professor
Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of breast cancer, including breast-conserving surgery for early-stage disease, sentinel lymph node biopsy, modified radical mastectomy for advanced cases, and minimally invasive surgery for benign conditions. Provides comprehensive care involving neoadjuvant and adjuvant chemotherapy, endocrine therapy, and targeted therapy.
Dr. Liu holds a PhD in Oncology from Harbin Medical University and completed postdoctoral training. After studying at Teikyo University in Japan, Dr. Liu joined Harbin Medical University Cancer Hospital in 2004, serving in abdominal and breast surgery. Dr. Liu conducted further studies at Fudan University Shanghai Cancer Center. Research includes provincial and ministerial projects, with publications in core domestic journals and six SCI-indexed articles.
Professional roles
- Member, Chinese Medical Doctor Association
- Member, Heilongjiang Anti-Cancer Association
Name order: in Chinese the family name comes first (Liu Feng). Papers usually list the name as Feng Liu or Liu F.
Selected publications
16 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Immunol, 2025 (senior author): Association of microtubule-based processes gene expression with immune microenvironment and its predictive value for drug response in oestrogen receptor-positive breast cancer. PubMed 40808956
- Discov Oncol, 2025 (senior author): Multi-omics analysis of the effects of pla2g4a on the prognosis of various cancers and its experimental validation in breast cancer cell lines. PubMed 40624348
- Breast Cancer (Dove Med Press), 2025 (senior author): The Comprehensive Analysis of Weighted Gene Co-Expression Network Analysis and Machine Learning Revealed Diagnostic Biomarkers for Breast Implant Illness Complicated with Breast Cancer. PubMed 40230814
- Clinics (Sao Paulo), 2023 (senior author): The effectiveness of ultrasound-guided core needle biopsy in detecting lymph node metastases in the axilla in patients with breast cancer: systematic review and meta-analysis. PubMed 37141768
- Crit Rev Eukaryot Gene Expr, 2023 (senior author): A Pan-Cancer Analysis to Provide Insight into the Immunological Role and Prognostic Value of HTRA3. PubMed 37606164
- Bioengineered, 2021 (senior author): MicroRNA -196b is related to the overall survival of patients with esophageal squamous cell carcinoma and facilitates tumor progression by regulating SOCS2 (Suppressor Of Cytokine Signaling 2). PubMed 34605350
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion